{"id":669986,"date":"2026-03-20T21:11:13","date_gmt":"2026-03-20T21:11:13","guid":{"rendered":"https:\/\/www.europesays.com\/us\/669986\/"},"modified":"2026-03-20T21:11:13","modified_gmt":"2026-03-20T21:11:13","slug":"abbott-closing-exact-sciences-acquisition-next-week-news","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/669986\/","title":{"rendered":"Abbott closing Exact Sciences acquisition next week | News"},"content":{"rendered":"<p>MADISON, Wis. &#8212; Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said.<\/p>\n<p>Madison-based Exact Sciences is known for its cancer detection technology such as Cologuard. Abbott announced last year that it would buy the company for $23 billion.<\/p>\n<p>&#8220;The addition of Exact Sciences enhances Abbott&#8217;s growth profile and strengthens our leadership in diagnostics,&#8221; Abbott chairman and CEO Robert Ford said in a statement on Friday. &#8220;This transaction brings a powerful new platform in cancer screening and diagnostics into Abbott, advancing our mission to make care more accessible and give people more control over their health.&#8221;<\/p>\n<p>Abbott said Friday that it had received all regulatory clearances for the acquisition.<\/p>\n<p>Originally founded in Massachusetts in 1995, Exact Sciences made the move to Madison in 2009.<\/p>\n<p>\u200bCOPYRIGHT 2026 BY CHANNEL 3000. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.<\/p>\n","protected":false},"excerpt":{"rendered":"MADISON, Wis. &#8212; Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said.&hellip;\n","protected":false},"author":3,"featured_media":669987,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[35],"tags":[13184,20861,235,282862,282863,134399,282861,210,1141,1142,67,132,68],"class_list":["post-669986","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-care","tag-abbott","tag-abbott-laboratories","tag-cancer","tag-cancer-detection-technology","tag-cologuard","tag-exact-sciences","tag-exact-sciences-corporation","tag-health","tag-health-care","tag-healthcare","tag-united-states","tag-unitedstates","tag-us"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/116263563033644642","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/669986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=669986"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/669986\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/669987"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=669986"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=669986"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=669986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}